SXTP Stock Falls 17% Despite GoodRx ARAKODA Partnership

SXTP Shares Decline Sharply Following GoodRx Deal Announcement

Shares of 60 Degrees Pharmaceuticals Inc, NASDAQ:SXTP, experienced a significant drop of 16.9% in premarket trading. This decline followed the announcement of a new partnership with GoodRx to offer prescription savings for its malaria prevention drug, ARAKODA.

Partnership Overview

The collaboration with GoodRx aims to make ARAKODA more accessible to travelers. The program will provide eligible patients with savings of up to 30%. ARAKODA, with the active ingredient tafenoquine, is the only once-weekly malaria prevention medication approved by the FDA currently available in the United States.

The discounted pricing will be available starting February 2, 2026, through the GoodRx platform at over 70,000 participating pharmacies nationwide.

Market Reaction and Impact

Despite the potential for increased drug accessibility and sales volume, the market reacted negatively to the news. The sharp sell-off suggests investor concern, possibly related to the financial terms of the partnership or its long-term impact on profit margins. The announcement did not detail specific reasons for the negative investor sentiment.

Summary and Outlook

The partnership between 60 Degrees Pharmaceuticals and GoodRx is strategically aimed at broadening patient access to ARAKODA. However, the immediate investor response was negative, reflected in the substantial premarket stock price decline. Market observers will monitor how this strategy affects the company's revenue and profitability moving forward.

FAQ

Q: Why did 60 Degrees Pharmaceuticals stock fall after the GoodRx partnership news?

A: The exact cause for the negative market reaction was not specified, but investors may have concerns about the deal's impact on profit margins or other financial terms despite the potential for increased sales.

Q: What is ARAKODA?

A: ARAKODA is an FDA-approved prescription medication used for the prevention of malaria. It is unique for its once-weekly dosing schedule, making it a convenient option for travelers.

Q: When will the GoodRx discount for ARAKODA be available?

A: The savings program through the GoodRx platform is scheduled to begin on February 2, 2026.

Source: Investing.com